Twist Bioscience Corporation (NAS: TWST) Stock Analysis & Fundamentals | ScreenerHero

Create free account

TWSTTwist Bioscience Corporation

NAS · US · Healthcare · Diagnostics & Research · twistbioscience.com

91.23USD-1.49%Mkt Cap: 5.68B $P/E: —1d ago

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.26BUSDP/E 43.7

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.21BUSDP/E 27.6

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.40BUSDP/E 22.0

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.73BUSDP/E 26.3

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.70BUSDP/E 43.3

GeneDx Holdings Corp.

Personalis, Inc.

Diagnostyka S.A.

$1.46BUSDP/E 22.1

Clínica Baviera, S.A.

$996.45MUSDP/E 20.9

OPKO Health, Inc.

Castle Biosciences, Inc.

$653.57MUSDP/E 42.6

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$292.59MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap5.68B $

Enterprise Value5.62B $

Revenue (TTM)409.48M $

Gross Profit191.00M $

Net Income (TTM)-77.67M $

Revenue/Share6.735 USD

Last Price91.23 USD

Fiscal Year EndSep 2025

MR QuarterMar 2026

Employees979

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS90184D1000

Valuation

P/E (Trailing)—

P/E (Forward)-119.52

PEG—

EV/EBITDA-51.17

EV/Revenue13.73

P/S13.87

P/B12.46

EPS (TTM)-1.32

EPS (Forward)-0.76

52W Range

23.3083% of range105.47

52W High105.47 USD

52W Low23.30 USD

Profitability

Gross Margin50.72%

Oper. Margin-34.92%

EBITDA Margin-26.82%

Profit Margin-20.63%

ROE-16.42%

ROA-12.10%

Growth

Revenue Growth19.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-47.63M $

CapEx (TTM)28.00M $

FCF Margin-14.28%

FCF Yield-1.03%

Net Debt-60.83M $

Net Debt/EBITDA0.55

Balance Sheet

Debt/Equity0.16

Current Ratio2.70

Quick Ratio2.04

Book Value/Sh7.322 USD

Cash/Share2.757 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)85.50 USD

Upside (mean)-6.3%

Target Range36.00 USD – 120.00 USD

$36.00-6.3% to mean$120.00

# Analysts10

Ownership

Shares Out.62.27M

Float55.37M

Insiders1.20%

Institutions124.31%

Short Interest

Short Ratio6.3d

Short % Float28.74%

Short % Out.22.40%

Shares Short13.95M

Short (prev mo.)14.90M

Technical

SMA 5074.85 (+21.9%)

SMA 20048.95 (+86.4%)

Beta2.12

S&P 52W Chg20.25%

Avg Vol (30d)1.92M

Avg Vol (10d)1.48M

Technical Indicators

RSI (14)56.1

MACD4.8556

MACD Signal6.5772

MACD Hist.-1.7216

BB Upper105.08 USD

BB Middle92.91 USD

BB Lower80.73 USD

BB Width26.21%

ATR (14)5.921 USD

Vol Ratio (20d)0.85x